This is the authors' abstract. We don't add key points for this paper.
The influence of caffeine on human health has been widely studied, but its relevance to hepatitis B virus (HBV) remains unclear. Here, we report that exogenous caffeine suppresses HBV RNA and core protein expression in hepatoma cells. Mechanistically, caffeine reduces the DNA damage marker γ -H2AX, which in turn diminishes HBV transcription. Functional assays revealed that γ -H2AX enhances HBV core promoter activity by facilitating the recruitment of peroxisome proliferator–activated receptor- α (PPARα). Chromatin immunoprecipitation confirmed that reduced γ -H2AX levels impair the binding of PPARα to the HBV core promoter. These findings establish a γ -H2AX–PPARα signaling axis that promotes HBV transcription and demonstrate that caffeine interferes with this pathway. In summary, our study demonstrated that γ -H2AX may serve as a nutritionally targetable node, supporting dietary and adjunct strategies for HBV management.
No takes yet. Share an insight, caveat, or question.
Liao et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: